PRJNA541589
Safety and Tolerability of Bacteriophage Therapy in Severe Staphylococcus aureus Infection
Longitudinal sampling of Staphylococcus aureus isolates from thirteen patients with severe S. aureus infections and who received AB-SA01 GMP bacteriophage cocktail as adjunctive therapy, administered intravenously twice daily for 14-day.